Location History:
- Jamaica Plain, MA (US) (1998 - 2003)
- Belmont, MA (US) (2000 - 2008)
Company Filing History:
4 out of 2,962 
4 out of 6 
3 out of 3 
Years Active: 1998-2008
Title: Roman M. Chicz: A Pioneer in Immunology Innovations
Introduction
Roman M. Chicz is a distinguished inventor based in Belmont, MA, known for his significant contributions in the field of immunology through his innovative research. With a total of 12 patents to his name, Chicz has made substantial advancements in understanding the role of peptide epitopes in the activation of CD4+ T lymphocytes, particularly in relation to autoimmune diseases.
Latest Patents
Among his latest innovations, Chicz has developed methods for identifying peptide epitopes that activate CD4+ T cells. These inventions are pivotal in understanding the pathogenesis of diseases, especially autoimmune disorders, where susceptibility is linked to the expression of specific class II MHC genes. His patents encompass peptides derived from the IA-2 polypeptide, altered peptide ligands, and therapeutic methods utilizing these altered peptides. The dual focus on innovative identification methods and therapeutic applications showcases his commitment to bridging research and clinical practice.
Career Highlights
Roman M. Chicz has been instrumental in advancing immunological research through his tenure at prestigious institutions like Harvard College and MGI Pharma Biologics, Inc. His work at these organizations has facilitated a deeper understanding of immune responses and provided the groundwork for future innovations in therapy.
Collaborations
Throughout his career, Roman has collaborated with notable professionals in the field, including Mary Lynne Hedley and Robert Glen Urban. These collaborations reflect his ability to work alongside talented individuals to foster innovation and drive research forward, enhancing the collective expertise in immunology.
Conclusion
Roman M. Chicz stands out as a prolific inventor in the realm of immunology, with a proven track record of patents that address critical aspects of autoimmune diseases. His contributions not only reflect his ingenuity but also pave the way for future advancements in therapeutic methods, highlighting the impact of his work on both scientific research and patient care.